Foong YC, Merlo D, Gresle M, Buzzard K, et al. Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60. J Neurol Neurosurg Psychiatry 2024 Mar 7:jnnp-2023-332883.
PMID: 38453478